BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37952244)

  • 1. Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report.
    Goldberg JF; Hyun G; Ness KK; Dixon SB; Towbin JA; Rhea IB; Ehrhardt MJ; Srivastava DK; Mulrooney DA; Hudson MM; Robison LL; Jefferies JL; Rohatgi A; Armstrong GT
    J Natl Cancer Inst; 2024 Mar; 116(3):408-420. PubMed ID: 37952244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia paradox: Analysis from the veterans exercise testing study.
    Vainshelboim B; Myers J
    PLoS One; 2023; 18(7):e0287923. PubMed ID: 37467298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia and its association with meibomian gland dysfunction.
    Braich PS; Howard MK; Singh JS
    Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia and cardiovascular disease risk among the MASHAD study population.
    Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M
    Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stunted Growth Is Associated With Dyslipidemia in Young Adults With Perinatal HIV Infection.
    Lesiapeto M; Shults J; Mmunyane M; Matshaba M; Lowenthal ED
    J Acquir Immune Defic Syndr; 2023 Aug; 93(4):343-350. PubMed ID: 37071712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
    Wu F; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Juonala M; Magnussen CG
    JAMA; 2024 Jun; 331(21):1834-1844. PubMed ID: 38607340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response to lifestyle counseling for dyslipidemia and elevated blood pressure in childhood cancer survivors.
    Javalkar K; Huang Y; Lyon SM; Palfrey H; Hartz J; Chen MH; de Ferranti S
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30034. PubMed ID: 36326745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden.
    Zhou Z; Ong KL; Whelton SP; Allison MA; Curtis AJ; Blaha MJ; Breslin M; Tonkin A; Magnussen CG; Budoff M; Nelson MR
    Mayo Clin Proc; 2022 Oct; 97(10):1883-1893. PubMed ID: 35760597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-year time-trend analysis of dyslipidemia among adults in Newfoundland and Labrador: findings from the laboratory information system between 2009 and 2014.
    Pedram P; Aref-Eshghi E; Mariathas HH; Hurley O; Godwin M; Duke P; Mahdavian M; Asghari S
    Lipids Health Dis; 2018 May; 17(1):99. PubMed ID: 29720176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study.
    Hammoud RA; Liu Q; Dixon SB; Onerup A; Mulrooney DA; Huang IC; Jefferies JL; Rhea IB; Ness KK; Ehrhardt MJ; Hudson MM; Ky B; Bhakta N; Sapkota Y; Yasui Y; Armstrong GT
    Lancet Oncol; 2024 Jun; 25(6):811-822. PubMed ID: 38821086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.